Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
GWPRF similar filings
Filing view
External links
Exhibit 13.2
Section 906 Certificate
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Adam George, Chief Financial Officer of GW Pharmaceuticals plc, a public limited company incorporated under English law (the “company”), hereby certify, to my knowledge, that:
1. | The Annual Report on Form 20-F for the year ended September 30, 2015 (the “Form 20-F”) of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the company. |
Date: December 7, 2015
/s/ Adam George | |
Adam George | |
Chief Financial Officer |